About Epilepsy Monitoring Devices
Epilepsy monitors sound an alarm or connect to a smartphone if they detect unusual movements, such as seizures. While these monitors can alert caregivers to a seizure, they cannot prevent the seizure from happening. Epilepsy monitors are devices that notify people when a seizure happens. This triggers an alarm so that the individual gets the assistance they need. According to the Epilepsy Foundation, these monitors can be particularly beneficial for children who may have seizures while they are asleep.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
High Growth Market | North America |
Unit | Value (USD Million) |
CAGR | 4.5% |
Epilepsy Monitoring Devices is a fragmented market due to the presence of various players. The players are focusing on strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Epilepsy Monitoring Devices market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Apple Inc. (United States), Emfit Ltd (Finland), Nihon Kohden Corporation (Japan), Empatica Inc. (United States), Natus Medical Incorporated (United States), Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), NeuroPace (United States), Epilepsy Alarms (United Kingdom) and Compumedics (Australia) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are UCB S.A. (Belgium) and Others.
Segmentation Overview
AMA Research has segmented the market of Global Epilepsy Monitoring Devices market by Type (Bed Monitors, Video Monitors and Wearables), Application (Home Care Setting, Hospitals and Clinics) and Region.
On the basis of geography, the market of Epilepsy Monitoring Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Asia Pacific region held largest market share in the year 2023. If we see Market by Features, the sub-segment i.e. WiFi Connectivity will boost the Epilepsy Monitoring Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Adults will boost the Epilepsy Monitoring Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Increasing Adoption of Wearable or Smart Remote-monitoring Epilepsy Devices in Different type of Healthcare Settings
Market Growth Drivers:
Growing Number of Epilepsy Health Problems in People and Need for Constant Monitoring and Improved Clinical Safety for Epilepsy Patients
Challenges:
Intense Competition in the Epilepsy Monitoring Devices Market with the Presence of Various Players
Restraints:
Regulatory Compliances and Standards Involved with Epilepsy Monitoring Devices
Opportunities:
Surging Research & Development Spendings or Investment in the Advanced Healthcare Equipment & Devices for Various Disease Diagnosis will Boost the Epilepsy Monitoring Devices
Market Leaders and their expansionary development strategies
In 2020, Magstim acquired EGI, a Philips subsidiary, to add high-density EEG solutions to its product portfolio. This acquisition has helped the company close the loop for developing comprehensive systems for non-invasive neuromodulation.
In August 2021, NeuroPace launched an epilepsy platform to personalize seizure care. It's able to gather information about a patient's seizures and health progress outside of a hospital. According to the company, the goal is to help provide doctors with new data points to help personalize care.
"FDA Approves mHealth Wearable for Tracking Epileptic Seizures. The FDA has approved a mHealth wearable for people living with epilepsy that's designed to detect convulsive seizures and immediately notify care team members."
Key Target Audience
Epilepsy Monitoring Devices Manufacturers, Epilepsy Monitoring Devices International Traders, Epilepsy Monitoring Devices Distributors and Suppliers, Research and Development Institutes, Potential Investors, Regulatory Bodies and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.